
Amarin Earnings, Revenue beat In Q3
Investing.com - Amarin reported third quarter {{erl-32541||earnings that beat analysts' expectations on Wednesday and revenue that topped forecasts. The firm reported earnings per share of...
Investing.com - Amarin reported third quarter {{erl-32541||earnings that beat analysts' expectations on Wednesday and revenue that topped forecasts. The firm reported earnings per share of...
-- U.S. Business Trends Stabilize and Progress on Operational Initiatives Result in Extended Cash Runway -- -- Commenced Launch of VAZKEPA® (icosapent ethyl) in England & Wales Mid-October...
Lars Ekman and Patrick O'Sullivan to Retire from Amarin Board at year-end New Independent Directors Bring Significant International Experience in Healthcare and Finance Seventy-five Percent...
An activist investment firm focusing on the pharmaceutical sector has put pressure on Amarin to hold a special meeting to straighten out its board issues and halt a slide.
Amarin Corp. (NASDAQ:AMRN) reported Q2 EPS of ($0.09), $0.03 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $90.6 million versus the consensus estimate of...
Investing.com - Amarin reported second quarter {{erl-32541||earnings that missed analysts' expectations on Wednesday and revenue that topped forecasts. The firm reported earnings per share...
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Oil & Gas, Technology and Telecoms sectors propelled shares higher. At the close in NYSE, the Dow Jones...
Investing.com - Amarin reported first quarter {{erl-32541||earnings that missed analysts' expectations on Wednesday and revenue that fell short of forecasts. The firm reported earnings per...
Amarin Corp. (NASDAQ:AMRN) reported Q1 EPS of ($0.08), $0.06 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $94.63 million versus the consensus estimate...
Investing.com - Amarin reported third quarter {{erl-32541||earnings that beat analysts' expectations on Wednesday and revenue that fell short of forecasts. The firm reported earnings per...
Investing.com - Amarin reported second quarter {{erl-32541||earnings that beat analysts' expectations on Thursday and revenue that topped forecasts. The firm reported earnings per share of...
Investing.com - Amarin reported first quarter {{erl-32541||earnings that beat analysts' expectations on Thursday and revenue that fell short of forecasts. The firm reported earnings per...
Investing.com - Amarin reported fourth quarter {{erl-32541||earnings that beat analysts' expectations on Thursday and revenue that topped forecasts. The firm reported earnings per share of...
Investing.com - Amarin reported third quarter {{erl-32541||earnings that matched analysts' expectations on Thursday and revenue that topped forecasts. The firm reported earnings per share...
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Utilities, Basic Materials and Healthcare sectors propelled shares higher. At the close in NYSE, the Dow...
Investing.com - Amarin reported second quarter {{erl-32541||earnings that beat analysts' expectations on Tuesday and revenue that fell short of forecasts. The firm reported earnings per...
Investing.com – U.S. equities were lower at the close on Tuesday, as losses in the Utilities, Financials and Telecoms sectors propelled shares lower. At the close in NYSE, the Dow Jones...
Investing.com – U.S. equities were mixed at the close on Monday, as gains in the Oil & Gas, Technology and Healthcare sectors propelled shares higher while losses in the Consumer Goods,...
Investing.com - Here are the top five things you need to know in financial markets on Wednesday, August 2: 1. Apple soars 6% on earnings beat Shares in {{erl-6408||Apple (NASDAQ:AAPL)...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.